Stockscreener 앱 받기
89.84
0.85%
0.76
시간 외 거래:
89.84
전일 마감가:
$89.08
열려 있는:
$88.62
하루 거래량:
1.79M
Relative Volume:
0.82
시가총액:
$17.58B
수익:
$8.23B
순이익/손실:
$705.10M
주가수익비율:
25.33
EPS:
3.5467
순현금흐름:
$1.12B
1주 성능:
-2.97%
1개월 성능:
-9.48%
6개월 성능:
-10.24%
1년 성능:
-20.43%
1일 변동 폭
$88.62
$90.76
1주일 범위
$88.62
$95.25
52주 변동 폭
$84.59
$114.44
짐머 바이오메트 Stock (ZBH) Company Profile
명칭
Zimmer Biomet Holdings Inc
전화
(574) 267-6131
주소
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
89.84 | 17.43B | 8.23B | 705.10M | 1.12B | 3.5467 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
짐머 바이오메트 Stock (ZBH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-20 | 개시 | William Blair | Mkt Perform |
| 2026-01-09 | 다운그레이드 | Goldman | Neutral → Sell |
| 2026-01-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-12-16 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-09-18 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-07-15 | 업그레이드 | Roth Capital | Neutral → Buy |
| 2024-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-09-10 | 개시 | Wolfe Research | Peer Perform |
| 2024-07-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-21 | 업그레이드 | Argus | Hold → Buy |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-10-20 | 개시 | ROTH MKM | Neutral |
| 2023-08-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-05-03 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-04-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-03-31 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-03-29 | 개시 | UBS | Sell |
| 2023-03-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Underweight |
| 2022-10-12 | 개시 | Jefferies | Underperform |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-04-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Underperform |
| 2022-03-02 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2022-02-08 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | 재확인 | Citigroup | Buy |
| 2022-02-08 | 재확인 | Deutsche Bank | Hold |
| 2022-02-08 | 재확인 | JMP Securities | Mkt Outperform |
| 2022-02-08 | 재확인 | JP Morgan | Neutral |
| 2022-02-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | 재확인 | Stifel | Buy |
| 2022-02-08 | 재확인 | Truist | Buy |
| 2022-02-08 | 재확인 | UBS | Neutral |
| 2022-02-08 | 재확인 | Wells Fargo | Underweight |
| 2022-02-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-01-19 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2021-12-07 | 개시 | Loop Capital | Buy |
| 2021-11-23 | 다운그레이드 | Argus | Buy → Hold |
| 2021-09-14 | 재개 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-09 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-18 | 재확인 | Needham | Strong Buy |
| 2020-10-20 | 개시 | Northland Capital | Market Perform |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-08-05 | 재확인 | Needham | Strong Buy |
| 2020-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-04-07 | 재확인 | Needham | Strong Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-07 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-09-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | 업그레이드 | Argus | Hold → Buy |
| 2019-07-30 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-07-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | 업그레이드 | Needham | Buy → Strong Buy |
모두보기
짐머 바이오메트 주식(ZBH)의 최신 뉴스
Surgical Equipment & ConsumablesDiversified Stocks Q4 In Review: Zimmer Biomet (NYSE:ZBH) Vs Peers - Yahoo Finance UK
Pre-market 19 Mar 2026: ZBH.SW Zimmer Biomet (SIX) CHF67.50 -4.26%: analyst grade - Meyka
Canaccord Genuity Maintains Zimmer Biomet Holdings (ZBH) Hold Recommendation - MSN
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
ZIMMER BIOMET HOLDINGS INCRo Khanna Congressional Trade on Feb. 05, 2026 - Quiver Quantitative
JPMorgan Chase & Co. Reduces Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings Stock (ISIN: US98956P1021) Faces Institutional Selling Pressure Amid Steady D - AD HOC NEWS
Moore Capital Management LP Trims Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Delta Global Management LP Makes New Investment in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Ameriprise Financial Inc. Has $373.24 Million Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Knee Replacement Market Set to Witness Significant Growth from - openPR.com
ZBH.SW down 4.26% pre-market on SIX: Zimmer Biomet faces near-term support test - Meyka
Zimmer Biomet declares $0.24 dividend - MSN
How Is Zimmer Biomet Holdings’ Stock Performance Compared to Other Medical Devices Stocks? - Barchart.com
Winkler Lori, SVP of Zimmer Biomet, sells $250k in stock - Investing.com
Zimmer Biomet Holdings Insider Sold Shares Worth $250,849, According to a Recent SEC Filing - marketscreener.com
Zimmer Biomet (NYSE:ZBH) SVP Sells $250,849.00 in Stock - MarketBeat
Zimmer Biomet (NYSE: ZBH) SVP sells 2,650 shares in open market - Stock Titan
Cash per share of Zimmer Biomet Holdings, Inc. – VIE:ZBH - TradingView
Is Zimmer Biomet’s Q4 Beat And 2026 Guidance Altering The Investment Case For ZBH? - simplywall.st
Zimmer Biomet tops Q4 expectations but strikes measured tone on 2026 guidance - MSN
Zimmer Biomet (ZBH) Valuation Check After Earnings Beat And Updated Growth Outlook - Yahoo Finance
Zimmer Biomet (ZBH) Valuation Check As AAOS 2026 Robotics And Smart Implant Showcase Nears - Sahm
Dodge & Cox Boosts Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
A Look At Zimmer Biomet (ZBH) Valuation After Mixed Recent Share Price Returns - simplywall.st
Zimmer Biomet outlines 2026 revenue growth of 1%–3% amid US sales force overhaul and innovation cycle - MSN
Zimmer Biomet Holdings, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Zimmer Biomet Holdings, Inc. Experiences Valuation Adjustment Amid Competitive Market Landscape - Markets Mojo
Korea Investment CORP Sells 79,643 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. $ZBH Shares Acquired by First Trust Advisors LP - MarketBeat
Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Why has Zimmer (ZBH) dropped 2% following its most recent earnings announcement? - Bitget
[144] ZIMMER BIOMET HOLDINGS, INC. SEC Filing - Stock Titan
Why Is Zimmer (ZBH) Down 2% Since Last Earnings Report? - Yahoo Finance
Zimmer Biomet Holdings, Inc. $ZBH Shares Sold by Swiss National Bank - MarketBeat
Citi Sticks to Their Hold Rating for Zimmer Biomet Holdings (ZBH) - The Globe and Mail
Sectors Review: What is the dividend yield of Zimmer Biomet Holdings Inc2026 Technical Overview & Community Verified Watchlist Alerts - baoquankhu1.vn
Orthobiologics Market to Surpass USD 9 Billion by 2031 Amid Rising Osteoarthritis Cases and Advancements in Regenerative Therapies, Says Mordor Intelligence - GlobeNewswire Inc.
Precision Trading with Zimmer Biomet Holdings Inc. (ZBH) Risk Zones - Stock Traders Daily
Richard Bernstein Advisors LLC Sells 18,526 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. $ZBH Shares Acquired by Capital International Inc. CA - MarketBeat
Capital International Investors Purchases 778,467 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
B. Metzler seel. Sohn & Co. AG Increases Stock Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Zimmer Biomet (NYSE: ZBH) CFO exercises RSUs and settles tax obligations in shares - Stock Titan
Zimmer Biomet (ZBH) executive exercises 7,004 RSUs, holds 30,991 shares - Stock Titan
Zimmer Biomet (NYSE: ZBH) SVP receives RSU stock; shares withheld for tax - Stock Titan
Zimmer Biomet (ZBH) CAO gains shares via RSU vesting and tax withholding - Stock Titan
Zimmer Biomet (ZBH) CEO nets more shares after RSU vesting and tax withholding - Stock Titan
Van ECK Associates Corp Buys 82,375 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. $ZBH Shares Sold by Barclays PLC - MarketBeat
짐머 바이오메트 (ZBH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.79%
1.86%
자본화:
|
볼륨(24시간):